Hazard
447 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all lack of sterility recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Oasis Medical, Inc. is recalling Oasis Tears PF preservative-free lubricant eye drops nationwide due to lack of assurance of sterility following FDA observations during an inspection.
CareFusion 213, LLC is recalling BD PurPrep (povidone-iodine 8.3% with isopropyl alcohol 72.5%) due to lack of assurance of sterility and potential product contamination. Affected lots are distributed nationwide.
Alcon Research LLC is recalling Systane Lubricant Eye Gel Night Gel (10g) distributed nationwide due to FDA inspection observations regarding lack of assurance of sterility that may impact product quality.
Scope Health is recalling Optase Dry Eye Intense Drops (Glycerin 0.2%) due to lack of assurance of sterility. The product is distributed nationwide.
B. Braun Medical Inc. is recalling sodium chloride for irrigation solution (3000 mL bags) due to lack of assurance of sterility and potential leakage from the diaphragm port. Affected lots distributed nationwide have expiration dates through May 31, 2028.
B. Braun Medical Inc. is recalling Sterile Water for Injection USP 3000 mL bags (24,928 units) distributed nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port.
Lidocaine Hydrochloride injection vials are being recalled nationwide because manufacturers cannot guarantee the product's sterility. All lots within expiration are affected.
International Medication Systems Ltd. is recalling epinephrine injection due to lack of assurance of sterility. The recall affects 81,520 units of lot EA038A5 distributed nationwide.
Bupivacaine Hydrochloride injectable anesthetic is being recalled due to lack of assurance of sterility. Approximately 3.26 million ampules distributed nationwide are affected.
Fresenius Kabi USA is recalling specific batches of 0.9% sodium chloride injection due to lack of assurance of sterility. The product is distributed nationwide, Alaska, and Puerto Rico.
Fresenius Kabi is recalling 5% Dextrose Injection due to lack of assurance of sterility. The affected batch was distributed nationwide in the US, including Alaska and Puerto Rico.
Fresenius Kabi recalled specific batches of 0.9% Sodium Chloride Injection due to lack of sterility assurance. Affected batches were distributed nationwide, Alaska, and Puerto Rico.
Fresenius Kabi USA, LLC is recalling batch 6402413 of 0.45% Sodium Chloride Injection, USP, due to lack of assurance of sterility. The affected batch was distributed nationwide, including Alaska and Puerto Rico.
Fresenius Kabi USA, LLC is recalling multiple batches of 0.9% sodium chloride intravenous injection due to lack of sterility assurance. No illnesses have been reported, but non-sterile IV solutions pose a risk of serious infection.
K.C. Pharmaceuticals recalls multiple brands of over-the-counter eye drops nationwide due to lack of assurance of sterility. Approximately 315,144 bottles are affected.
Multiple brands of artificial tears eye drops are being recalled nationwide due to lack of sterility assurance. Over 1 million bottles are affected.
Apotex Corp. is recalling brimonidine tartrate/timolol maleate ophthalmic solution nationwide due to lack of sterility assurance. The recall affects 107,136 vials across two lots.
New Life Pharma LLC recalled 45 vials of Tirzepatide 15mg injectable due to lack of assurance of sterility. The affected lot was distributed in Ohio.
ProRx is recalling 8,310 vials of semaglutide injection due to lack of sterility assurance. The affected lots were distributed in Texas and Utah.
ProRx LLC is recalling 2,761 vials of Tirzepatide Injection due to lack of assurance of sterility. The affected lot was distributed to Texas and Utah.
GenoGenix LLC is recalling all lots of L-Glutamine for Injection nationwide because the company cannot assure the product meets sterility requirements for safe injection.
BPC-157/Thymosin Beta-4 injections from GenoGenix are being recalled due to lack of assurance of sterility. The recall affects products distributed nationwide.
GenoGenix LLC is recalling all strengths of Glycine for Injection distributed nationwide due to lack of assurance of sterility. No illnesses have been reported.
GenoGenix, LLC is recalling all lots of N-Acetyl-L-Cysteine for Injection due to lack of assurance of sterility. All strengths and presentations distributed nationwide in the U.S. are affected.
GenoGenix LLC is recalling all lots of EDTA for Injection nationwide due to lack of assurance of sterility, affecting all strengths and presentations.